Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

COLL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.98%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,618,056.46

Collegium Pharmaceutical Insider Trading History Chart

Collegium Pharmaceutical Share Price & Price History

^$39.07

▲ +0.14 (0.36%)

As of 09/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump’s weapon lurks in abandoned America

From Porter & Company | Ad

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

Go here now to watch my new documentary

Collegium Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/13/2024	Thomas B Smith	EVP	Sell	9,593	$36.62	$351,295.66	53,816
9/5/2024	Shirley R. Kuhlmann	EVP	Sell	19,248	$38.30	$737,198.40	120,161
5/28/2024	Colleen Tupper	CFO	Sell	19,710	$34.21	$674,279.10	130,845
5/24/2024	Scott Dreyer	EVP	Sell	56,807	$33.98	$1,930,301.86	105,902
5/14/2024	Garen G Bohlin	Director	Sell	28,985	$32.30	$936,215.50	44,775
1/16/2024	Scott Dreyer	EVP	Sell	23,560	$32.28	$760,516.80	111,322
12/21/2023	Joseph Ciaffoni	CEO	Sell	4,357	$30.38	$132,365.66	275,000
12/19/2023	Joseph Ciaffoni	CEO	Sell	14,516	$30.03	$435,915.48	275,000
11/27/2023	Shirley R. Kuhlmann	EVP	Sell	25,600	$25.78	$659,968.00	119,518
6/26/2023	Shirley R. Kuhlmann	EVP	Sell	17,984	$21.72	$390,612.48	119,518
6/1/2023	Joseph Ciaffoni	CEO	Sell	31,272	$22.09	$690,798.48	306,272
5/30/2023	Joseph Ciaffoni	CEO	Sell	31,271	$21.90	$684,834.90	368,816
3/15/2023	Colleen Tupper	CFO	Sell	31,640	$23.77	$752,082.80	105,420
3/1/2023	Scott Dreyer	EVP	Sell	13,324	$26.70	$355,750.80	134,882
2/13/2023	Joseph Ciaffoni	CEO	Sell	11,250	$26.88	$302,400.00	400,087
2/13/2023	Shirley R. Kuhlmann	EVP	Sell	21,811	$26.88	$586,279.68	137,502
1/9/2023	Scott Dreyer	EVP	Sell	17,834	$27.39	$488,473.26	102,798
12/27/2022	Joseph Ciaffoni	CEO	Sell	2,204	$23.75	$52,345.00	248,750
12/27/2022	Michael Thomas Heffernan	Director	Sell	19,815	$23.73	$470,209.95	28,023
12/23/2022	Joseph Ciaffoni	CEO	Sell	147	$23.00	$3,381.00	250,954
12/22/2022	Michael Thomas Heffernan	Director	Sell	237	$23.00	$5,451.00	28,023
12/21/2022	Joseph Ciaffoni	CEO	Sell	7,333	$23.11	$169,465.63	251,211
12/20/2022	Michael Thomas Heffernan	Director	Sell	33,758	$23.08	$779,134.64	28,023
12/19/2022	Joseph Ciaffoni	CEO	Sell	1,134	$23.01	$26,093.34	267,919
12/12/2022	Michael Thomas Heffernan	Director	Sell	27,920	$22.01	$614,519.20	28,023
12/1/2022	Joseph Ciaffoni	CEO	Sell	76,653	$22.47	$1,722,392.91	323,453
11/28/2022	Joseph Ciaffoni	CEO	Sell	43	$22.00	$946.00	323,453
11/22/2022	Joseph Ciaffoni	CEO	Sell	65	$22.00	$1,430.00	323,453
11/18/2022	Joseph Ciaffoni	CEO	Sell	1,989	$22.02	$43,797.78	323,453
10/4/2022	Colleen Tupper	CFO	Sell	4,350	$17.35	$75,472.50	90,304
9/15/2022	Shirley R. Kuhlmann	EVP	Sell	38,589	$18.07	$697,303.23	109,495
8/11/2022	Shirley R. Kuhlmann	EVP	Sell	300	$20.01	$6,003.00	148,084
2/18/2022	Scott Dreyer	EVP	Sell	10,559	$21.61	$228,179.99
12/15/2021	Scott Dreyer	EVP	Sell	5,693	$18.33	$104,352.69

Ex-Wall Street CEO reveals “Millionaire-Maker” Superdrug

From Behind the Markets | Ad

Science Magazine called it the "breakthrough of the year"... With projections of 8,966% growth in the next four years.

Click here for our #1 "Retirement Window" Stock >>>

SEC Filings (Institutional Ownership Changes) for Collegium Pharmaceutical (NASDAQ:COLL)

Institutional Buying and Selling by Quarter

Collegium Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/5/2024	Sanctuary Advisors LLC	16,245	$0.52M	0.0%	N/A	0.050%
8/15/2024	Millennium Management LLC	303,870	$9.79M	0.0%	+57.1%	0.929%
8/15/2024	Maverick Capital Ltd.	39,596	$1.28M	0.0%	+346.3%	0.121%
8/15/2024	Deerfield Management Company L.P. Series C	13,296	$0.43M	0.0%	+65.9%	0.041%
8/15/2024	AQR Capital Management LLC	101,956	$3.28M	0.0%	-6.6%	0.312%
8/15/2024	AXA S.A.	6,501	$0.21M	0.0%	N/A	0.020%
8/15/2024	Caxton Associates LP	53,611	$1.73M	0.1%	+20.3%	0.164%
8/14/2024	Squarepoint Ops LLC	110,338	$3.55M	0.0%	+194.5%	0.337%
8/14/2024	Marshall Wace LLP	70,964	$2.29M	0.0%	N/A	0.217%
8/14/2024	Public Sector Pension Investment Board	71,941	$2.32M	0.0%	+7.6%	0.220%
8/14/2024	ProShare Advisors LLC	7,053	$0.23M	0.0%	-20.1%	0.022%
8/14/2024	Profund Advisors LLC	8,805	$0.28M	0.0%	+52.7%	0.027%
8/13/2024	Rubric Capital Management LP	2,333,500	$75.14M	2.0%	+27.2%	7.133%
8/13/2024	Thrivent Financial for Lutherans	27,158	$0.87M	0.0%	-4.0%	0.083%
8/13/2024	Sei Investments Co.	9,498	$0.31M	0.0%	-53.3%	0.029%
8/13/2024	Pacer Advisors Inc.	3,408,369	$109.75M	0.2%	+31.8%	10.418%
8/12/2024	Inspire Investing LLC	24,798	$0.80M	0.1%	+13.3%	0.076%
8/12/2024	Hsbc Holdings PLC	20,588	$0.66M	0.0%	-3.4%	0.063%
8/10/2024	Mutual of America Capital Management LLC	75,928	$2.45M	0.0%	-18.2%	0.232%
8/9/2024	Renaissance Technologies LLC	1,531,498	$49.31M	0.1%	+8.0%	4.681%
8/9/2024	Dimensional Fund Advisors LP	1,039,024	$33.46M	0.0%	+2.0%	3.176%
8/9/2024	Massachusetts Financial Services Co. MA	649,365	$20.91M	0.0%	-1.9%	1.985%
8/8/2024	BOKF NA	15,208	$0.49M	0.0%	N/A	0.046%
8/8/2024	Johnson Investment Counsel Inc.	6,436	$0.21M	0.0%	-12.1%	0.020%
8/8/2024	American Century Companies Inc.	99,808	$3.21M	0.0%	+8.8%	0.305%
8/7/2024	Texas Permanent School Fund Corp	25,365	$0.82M	0.0%	-11.1%	0.078%
8/7/2024	Choreo LLC	12,150	$0.40M	0.0%	N/A	0.037%
8/6/2024	Quest Partners LLC	18,827	$0.61M	0.1%	+186.0%	0.058%
8/6/2024	Emerald Advisers LLC	650,173	$20.94M	0.9%	-2.9%	1.987%
8/6/2024	Emerald Mutual Fund Advisers Trust	530,456	$17.08M	0.9%	+3.8%	1.621%
8/6/2024	Gallacher Capital Management LLC	9,338	$0.30M	0.2%	+62.2%	0.029%
8/6/2024	Los Angeles Capital Management LLC	59,911	$1.93M	0.0%	-9.1%	0.183%
8/5/2024	Foundry Partners LLC	15,272	$0.49M	0.0%	N/A	0.047%
8/5/2024	Victory Capital Management Inc.	494,814	$15.93M	0.0%	-5.9%	1.512%
8/3/2024	TD Asset Management Inc	15,000	$0.48M	0.0%	+172.7%	0.046%
8/2/2024	Acorn Financial Advisory Services Inc. ADV	30,942	$1M	0.2%	-21.2%	0.095%
8/1/2024	Rhumbline Advisers	107,364	$3.46M	0.0%	+2.8%	0.328%
8/1/2024	Versor Investments LP	8,368	$0.27M	0.0%	-31.8%	0.026%
8/1/2024	Natixis Advisors LLC	24,665	$0.79M	0.0%	-11.7%	0.075%
8/1/2024	Ritholtz Wealth Management	38,856	$1.25M	0.0%	+43.1%	0.119%
7/31/2024	nVerses Capital LLC	1,700	$55K	0.0%	+1,600.0%	0.005%
7/30/2024	Maryland State Retirement & Pension System	11,406	$0.37M	0.0%	-3.8%	0.035%
7/29/2024	Principal Financial Group Inc.	1,680,860	$54.12M	0.0%	+8.2%	5.138%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,745	$0.31M	0.0%	+10.9%	0.030%
7/26/2024	Allspring Global Investments Holdings LLC	43,491	$1.40M	0.0%	-4.3%	0.133%
7/26/2024	Bank of New York Mellon Corp	296,730	$9.56M	0.0%	-3.5%	0.907%
7/25/2024	Easterly Investment Partners LLC	42,629	$1.37M	0.1%	-14.1%	0.130%
7/24/2024	Louisiana State Employees Retirement System	16,500	$0.53M	0.0%	+1.9%	0.050%
7/24/2024	SummerHaven Investment Management LLC	34,773	$1.12M	0.7%	+1.3%	0.106%
7/19/2024	Values First Advisors Inc.	16,993	$0.55M	0.3%	+6.6%	0.052%
7/19/2024	Gladius Capital Management LP	992	$32K	0.0%	N/A	0.003%
7/18/2024	Assenagon Asset Management S.A.	362,137	$11.66M	0.0%	+411.1%	1.107%
7/17/2024	Wedge Capital Management L L P NC	46,205	$1.49M	0.0%	+7.2%	0.141%
7/16/2024	RHS Financial LLC	9,428	$0.30M	0.2%	N/A	0.029%
7/12/2024	Thrive Wealth Management LLC	23,976	$0.77M	0.2%	N/A	0.073%
7/12/2024	SG Americas Securities LLC	16,815	$0.54M	0.0%	+19.9%	0.051%
7/9/2024	Harbor Capital Advisors Inc.	22,515	$0.73M	0.1%	+64.7%	0.069%
5/17/2024	Comerica Bank	25,082	$0.97M	0.0%	+62.5%	0.077%
5/16/2024	California State Teachers Retirement System	32,624	$1.27M	0.0%	-11.2%	0.100%
5/16/2024	Janus Henderson Group PLC	563,405	$21.87M	0.0%	-10.2%	1.722%
5/16/2024	Caxton Associates LP	44,565	$1.73M	0.1%	N/A	0.136%
5/15/2024	Price T Rowe Associates Inc. MD	29,282	$1.14M	0.0%	+1.9%	0.089%
5/14/2024	Sheaff Brock Investment Advisors LLC	5,250	$0.20M	0.0%	N/A	0.016%
5/14/2024	EntryPoint Capital LLC	2,240	$87K	0.1%	-30.3%	0.007%
5/14/2024	CANADA LIFE ASSURANCE Co	31,852	$1.24M	0.0%	+17.5%	0.097%
5/14/2024	American International Group Inc.	17,624	$0.68M	0.0%	-6.1%	0.054%
5/13/2024	O Shaughnessy Asset Management LLC	45,735	$1.78M	0.0%	+159.3%	0.140%
5/11/2024	Hillsdale Investment Management Inc.	111,500	$4.33M	0.3%	+18.2%	0.341%
5/10/2024	Vanguard Group Inc.	2,330,728	$90.48M	0.0%	+0.8%	7.126%
5/9/2024	State Board of Administration of Florida Retirement System	15,410	$0.60M	0.0%	+55.8%	0.047%
5/8/2024	ProShare Advisors LLC	8,826	$0.34M	0.0%	+3.3%	0.027%
5/8/2024	Russell Investments Group Ltd.	33,084	$1.28M	0.0%	+3.2%	0.101%
5/8/2024	Inspire Investing LLC	21,881	$0.85M	0.1%	-13.7%	0.067%
5/7/2024	Sei Investments Co.	20,329	$0.79M	0.0%	-84.3%	0.062%
5/7/2024	Swiss National Bank	64,400	$2.50M	0.0%	-6.0%	0.197%
5/7/2024	Illinois Municipal Retirement Fund	18,544	$0.72M	0.0%	-6.7%	0.057%
5/7/2024	SG Americas Securities LLC	14,030	$0.55M	0.0%	-23.1%	0.043%
5/6/2024	Quantbot Technologies LP	9,487	$0.37M	0.0%	-4.9%	0.029%
5/6/2024	LSV Asset Management	380,551	$14.77M	0.0%	+188.7%	1.163%
5/6/2024	Gallacher Capital Management LLC	5,756	$0.22M	0.1%	N/A	0.018%
5/6/2024	Texas Permanent School Fund Corp	28,541	$1.11M	0.0%	+1.3%	0.087%
5/2/2024	Mutual of America Capital Management LLC	92,802	$3.60M	0.0%	-7.2%	0.284%
5/1/2024	Janney Montgomery Scott LLC	13,370	$0.52M	0.0%	N/A	0.041%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	15,978	$0.62M	0.0%	-4.4%	0.049%
4/29/2024	Principal Financial Group Inc.	1,552,857	$60.28M	0.0%	-1.0%	4.748%
4/29/2024	Meritage Portfolio Management	8,141	$0.32M	0.0%	N/A	0.025%
4/29/2024	China Universal Asset Management Co. Ltd.	6,120	$0.24M	0.0%	+62.1%	0.019%
4/26/2024	Yousif Capital Management LLC	14,894	$0.58M	0.0%	-18.4%	0.046%
4/25/2024	New York State Teachers Retirement System	13,298	$0.52M	0.0%	+6.6%	0.041%
4/24/2024	Assenagon Asset Management S.A.	70,851	$2.75M	0.0%	-79.5%	0.217%
4/23/2024	Nations Financial Group Inc. IA ADV	9,936	$0.39M	0.0%	N/A	0.030%
4/18/2024	Allspring Global Investments Holdings LLC	45,438	$1.76M	0.0%	-0.9%	0.139%
4/5/2024	Los Angeles Capital Management LLC	65,940	$2.56M	0.0%	-6.5%	0.206%
3/26/2024	HighPoint Advisor Group LLC	16,685	$0.51M	0.0%	N/A	0.052%
2/20/2024	Eventide Asset Management LLC	2,630,478	$80.97M	1.3%	0.0%	8.066%
2/15/2024	Penn Capital Management Company LLC	315,774	$9.76M	0.9%	N/A	0.968%
2/14/2024	Avidity Partners Management LP	361,363	$11.12M	0.4%	+3.2%	1.108%
2/14/2024	Rubric Capital Management LP	2,758,253	$84.90M	1.7%	-13.1%	8.458%
2/14/2024	Third Avenue Management LLC	83,120	$2.56M	0.4%	N/A	0.255%
2/9/2024	Aigen Investment Management LP	10,994	$0.34M	0.1%	N/A	0.034%

Data available starting January 2016

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Today's Range

Now: $39.07

$38.29

$39.41

50 Day Range

MA: $36.09

$31.78

$39.07

52 Week Range

Now: $39.07

$20.95

$40.95

Volume

1,646,386 shs

Average Volume

452,405 shs

Market Capitalization

$1.28 billion

P/E Ratio

16.28

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Collegium Pharmaceutical?: Collegium Pharmaceutical's top insider investors include:
Joseph Ciaffoni (CEO)
Shirley R Kuhlmann (EVP)
Scott Dreyer (EVP)
Colleen Tupper (CFO)
Thomas B Smith (EVP)
Garen G Bohlin (Director)
Michael Thomas Heffernan (Director)
Learn More about top insider investors at Collegium Pharmaceutical.
Who are the major institutional investors of Collegium Pharmaceutical?: Collegium Pharmaceutical's top institutional investors include:
Pacer Advisors Inc. — 10.42%
Rubric Capital Management LP — 7.13%
Principal Financial Group Inc. — 5.14%
Renaissance Technologies LLC — 4.68%
Dimensional Fund Advisors LP — 3.18%
Emerald Advisers LLC — 1.99%
Learn More about top institutional investors of Collegium Pharmaceutical stock.
Which institutional investors are selling Collegium Pharmaceutical stock?: In the previous quarter, COLL stock was sold by these institutional investors:
Victory Capital Management Inc.
Emerald Advisers LLC
Mutual of America Capital Management LLC
Massachusetts Financial Services Co. MA
Bank of New York Mellon Corp
Sei Investments Co.
Acorn Financial Advisory Services Inc. ADV
AQR Capital Management LLC
During the last year, company insiders that have sold Collegium Pharmaceutical company stock include:
Joseph Ciaffoni (CEO)
Shirley R Kuhlmann (EVP)
Scott Dreyer (EVP)
Colleen Tupper (CFO)
Thomas B Smith (EVP)
Garen G Bohlin (Director)
Learn More investors selling Collegium Pharmaceutical stock.
Which institutional investors are buying Collegium Pharmaceutical stock?: Within the previous quarter, COLL stock was acquired by institutional investors including:
Pacer Advisors Inc.
Rubric Capital Management LP
Assenagon Asset Management S.A.
Principal Financial Group Inc.
Renaissance Technologies LLC
Millennium Management LLC
Squarepoint Ops LLC
Marshall Wace LLP

The death of Nvidia?